Compare NMG & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMG | TMCI |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.7M | 292.0M |
| IPO Year | 2015 | 2021 |
| Metric | NMG | TMCI |
|---|---|---|
| Price | $0.94 | $4.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | $3.68 | ★ $5.50 |
| AVG Volume (30 Days) | ★ 438.5K | 202.1K |
| Earning Date | 11-11-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $0.87 | $1.17 |
| 52 Week High | $3.59 | $6.65 |
| Indicator | NMG | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 35.55 | 51.61 |
| Support Level | $0.87 | $4.31 |
| Resistance Level | $2.42 | $4.72 |
| Average True Range (ATR) | 0.06 | 0.26 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 40.00 | 42.46 |
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.